Explore the words cloud of the SiNBioSys project. It provides you a very rough idea of what is the project "SiNBioSys" about.
The following table provides information about the project.
Coordinator |
ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA
Organization address contact info |
Coordinator Country | Italy [IT] |
Total cost | 149˙937 € |
EC max contribution | 149˙937 € (100%) |
Programme |
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC)) |
Code Call | ERC-2017-PoC |
Funding Scheme | ERC-POC |
Starting year | 2017 |
Duration (year-month-day) | from 2017-11-01 to 2019-04-30 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA | IT (BOLOGNA) | coordinator | 149˙937.00 |
Optical imaging is a powerful tool for light-guided surgery and for the study of biological functions via dynamic visualization of processes in tissues and cells. Most of optical imaging techniques utilise fluorescent probes that can suffer from low contrast, due to scattering of the excitation light, and low tissue penetration. Silicon nanocrystals (SiNCs), developed within the ERC PhotoSi project, are a very promising alternative for this purpose: silicon is essentially non-toxic, easily available, and it can be covalently linked with dyes. The result is a highly-robust and biocompatible hybrid material, which exhibits colour tunability across the visible and near-infrared region. On top of that, the extraordinary brightness of the material coupled to a long-lived luminescence (lifetime of the hundreds of microseconds) enables time-gated detection. Therefore, SiNBioSys technology greatly improves the contrast of the obtained images with a low-cost equipment and with a material based on abundant and biocompatible elements (Si, C, O, H). An international patent application on the key underlying technology was filed in 2015 and subsequently nationalized in the primary markets (Europe and USA). Based on these premises, this proposal is intended to gather sufficient technical and commercial evidence to make the SiNBioSys technology attractive for further investment in the development of a new commercial product by: (i) optimization and validation of SiNCs against current gold standards; (ii) an in-depth market analysis; (iii) a realistic business development strategy with demonstrations to leading companies in the field. The proposed technology will thus bring an economic impact, as well as social benefits: it will demonstrate its ability to replace currently used expensive setups and will enable innovative imaging tools for early diagnosis of diseases, particularly in the field of cancer and neuroscience.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SINBIOSYS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "SINBIOSYS" are provided by the European Opendata Portal: CORDIS opendata.